| Autor: |
Mehrdad Hashemi, Sophie Mousavian Roshanzamir, Sima Orouei, Pouria Daneii, Rasoul Raesi, Haleh Zokaee, Pooria Bikarannejad, Kiana Salmani, Ramin Khorrami, Mahshid Deldar Abad Paskeh, Shokooh Salimimoghadam, Mohsen Rashidi, Kiavash Hushmandi, Afshin Taheriazam, Maliheh Entezari |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
Non-coding RNA Research, Vol 9, Iss 2, Pp 508-522 (2024) |
| Druh dokumentu: |
article |
| ISSN: |
2468-0540 |
| DOI: |
10.1016/j.ncrna.2024.02.002 |
| Popis: |
The brain tumors and especially glioblastoma, are affecting life of many people worldwide and due to their high mortality and morbidity, their treatment is of importance and has gained attention in recent years. The abnormal expression of genes is commonly observed in GBM and long non-coding RNAs (lncRNAs) have demonstrated dysregulation in this tumor. LncRNAs have length more than 200 nucleotides and they have been located in cytoplasm and nucleus. The current review focuses on the role of lncRNAs in GBM. There two types of lncRNAs in GBM including tumor-promoting and tumor-suppressor lncRNAs and overexpression of oncogenic lncRNAs increases progression of GBM. LncRNAs can regulate proliferation, cell cycle arrest and metastasis of GBM cells. Wnt, STAT3 and EZH2 are among the molecular pathways affected by lncRNAs in GBM and for regulating metastasis of GBM cells, these RNA molecules mainly affect EMT mechanism. LncRNAs are involved in drug resistance and can induce resistance of GBM cells to temozolomide chemotherapy. Furthermore, lncRNAs stimulate radio-resistance in GBM cells. LncRNAs increase PD-1 expression to mediate immune evasion. LncRNAs can be considered as diagnostic and prognostic tools in GBM and researchers have developed signature from lncRNAs in GBM. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
